期刊文献+

放疗联合多西紫杉醇与奥沙利铂方案同步化疗治疗食管上段癌的近期疗效分析

下载PDF
导出
摘要 目的:观察放疗联合多西紫杉醇(docetaxel)、奥沙利铂(Carboplatin)治疗食管上段癌的近期疗效及耐受性。方法:42例初治原发食管上段鳞癌患者采用常规分割放疗加TXT、Carboplatin同期化疗。接受常规分割放疗60Gy,30分割,同期化疗:多西紫杉醇75mg/m2第1天、Carboplatin 120mg/m2第1天,每28天重复,共4周期。结果:42例全部完成治疗计划,CR和PR分别为59.5%(25/42)和26.1%(11/42)最主要的不良反应为白细胞及血小板降低,但均可耐受。结论:放疗联合多docetaxel、Carboplatin治疗食管上段癌同步治疗食管上段癌近期疗效较好,不良反应能为大多数患者耐受。
出处 《中国社区医师(医学专业)》 2011年第24期90-91,共2页
  • 相关文献

参考文献5

  • 1Al-Sarraf M,MartzK,HerskovicA,et al.Progress reportof combineel Chemoradiotherapy Versus radiotherapy alone in patients with esophageal cancer:a intergroop study[J].J Clin Oncol,1997,15:277-284.
  • 2胡晓璐,杨毅,李高峰,陈瑞斌,王巍炜.放疗联合NP方案同步化疗治疗食管上段癌的近期疗效分析[J].中国医学创新,2010,7(20):62-63. 被引量:1
  • 3Copper JS,GuoMD,Herskovic A,et al.Chemoradio-therapy of locally advance espophageal cancer:long-termfollow-up of a prospective randomized trial (ROTG 8501)Radiation Theraphy Oncology Group[J].JAMA,1999,281(17):1623-1627.
  • 4张琴,陈德玉,刘俊,李君荣.食管癌同期放化疗的疗效分析[J].江苏大学学报(医学版),2008,18(1):79-81. 被引量:17
  • 5Wong R,Malthaner R.Combined chemoradiotherapy(without surgery) compared with radiotherapy alone inl ocalized carcinoma of the esophagus[J].Cochrane Data base Syst Rev,2006,25(1):2092.

二级参考文献12

  • 1任宝志,山长平,韩磊,朱培军.Ⅲ期食管癌后程加速超分割三维适形放射治疗协同化疗的疗效分析[J].中华放射肿瘤学杂志,2004,13(4):265-267. 被引量:37
  • 2陈尔成,刘孟忠,胡永红,李巧巧,刘慧,蔡玲,刘慧,林焕新,黄莹,王汉渝,崔念基.不能手术切除行同期放化疗的食管癌患者预后的多因素分析[J].癌症,2005,24(6):731-734. 被引量:38
  • 3Asakura H,Takashima H,Yokoe K,et al.Hyperfractionated radio-therapy with concurrent chemotherapy for advanced esophageal cancer.Gan ToKagaku Ryoho,2005,32(9):1279-1282.
  • 4Fiorica F,Di Bona D,Schepis F,et al.Preoperative chemoradiotherapy for esophageal cancer:a systematic review and meta-analysis.Gut,2004,53:925-930.
  • 5Wong R,Malthaner R.Combined chemoradiotherapy(without surgery)compared with radiotherapy alone inl ocalized carcinoma of the esophagus.Cochrane Data base Syst Rev,2006,25(1):CD002092.
  • 6Seydel HG, Leichman L, Byhardt R, et al. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: an RTOG study [J]. Int J Radiat Oncol Biol Phys, 1998, 14( 1 ): 33 -35.
  • 7Kelsen DP. Multi-modality therapy of esophagerl cancer: an up-date [J]. Cancer J, 2000, 6(suppl 2):S177 - 181.
  • 8Copper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advance espophageal cancer: long-term follow-up of a prospective randomized trial ( ROTG 85 - 01 ) Radiation Theraphy Oncology Group [ J ]. JAMA, 1999,281(17) : 1623 - 1627.
  • 9Wong RK, Malthaner RA, Zuraw L, et al. Combined modalityradiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline [ J]. Int J Radiat Oncol Biol Phys, 2003, 55 (4): 930-942.
  • 10Wong R, Malthaner R. Combined chemoradiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus [ J ]. Cochrane Database Syst Rev, 2006, 25 ( 1 ) : CD002092.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部